section name header

Basics

Outline


BASICS

Overview!!navigator!!

  • The glaucomas are a group of diseases resulting from alterations of aqueous humor dynamics that cause an IOP increase above that which is compatible with normal function of the retinal ganglion cells and optic nerve
  • Glaucoma in horses is being recognized with increased frequency, although the prevalence of glaucoma in the horse is surprisingly low given the horse's propensity for ocular injury and marked intraocular inflammatory responses
  • All glaucomas consist of 5 stages: (1) an initial event or series of events that influence the aqueous humor outflow system; (2) morphologic alterations of the aqueous outflow system that eventually lead to aqueous outflow obstruction and IOP elevation; (3) elevated IOP or ocular hypertension that severely reduces retinal ganglion cell sensitivity and function; (4) subsequent retinal ganglion cell and optic nerve axon degeneration; and (5) progressive visual deterioration that eventually leads to blindness
  • The glaucomas are frequently categorized into primary, secondary, and congenital types. While all types of glaucoma have a causative mechanism, primary glaucomas possess no overt ocular abnormality to account for the increase in IOP, whereas secondary glaucomas have an identifiable cause, such as intraocular inflammation, neoplasia, or lens luxation
  • Primary bilateral glaucoma has been rarely reported in the horse
  • Secondary glaucomas due to anterior uveitis and intraocular neoplasia are most commonly recognized in the horse
  • Congenital glaucoma is reported in foals and associated with developmental anomalies of the iridocorneal angle

Signalment!!navigator!!

  • Glaucoma is reported in the Appaloosa, Paso Fino, Thoroughbred, and Warmblood, although all ages and breeds of horses are at risk
  • There appears to be an increased incidence of glaucoma in horses with chronic uveitis, such as those with ERU, horses >15 years old, and Appaloosas

Signs!!navigator!!

  • Equine glaucoma may not be easily recognized in the early stages of the disease due to the subtle nature of the clinical signs
  • Initially, the pupils of affected eyes are often only slightly mydriatic, and overt discomfort is uncommon
  • Afferent pupillary light reflex deficits, corneal striae, fibrosis of the drainage angle, decreased vision, lens subluxations and luxations, mild iridocyclitis, and optic nerve atrophy/cupping may also be found in eyes of horses with glaucoma
  • The presence of corneal striae, or corneal endothelial “band opacities,” in non-buphthalmic horse eyes warrants a high degree of suspicion for the finding of elevated IOP, which may also be found in eyes that are normotensive at the time of examination. Corneal striae are linear, often interconnecting or branching, white opacities found deep in the cornea, caused by stretching or rupture of Descemet's membrane, and may be associated with increased IOP

Causes and Risk Factors!!navigator!!

  • Aqueous humor is produced in the ciliary body by energy-dependent and -independent mechanisms. The ciliary enzyme carbonic anhydrase plays an important role in aqueous production. Aqueous humor passes into the posterior chamber, through the pupil into the anterior chamber, and then exits through the iridocorneal angle (conventional) outflow pathway or through the uveovortex and uveoscleral (unconventional) outflow pathways
  • Perfusion and morphologic studies indicate potentially extensive unconventional aqueous humor outflow pathway involvement in the horse. The extensive low-resistance equine conventional aqueous humor outflow pathway and the prominent unconventional outflow pathways in the horse may minimize development of glaucoma in many cases of anterior uveitis
  • However, anterior uveitis can lead to formation of preiridal fibrovascular membranes that limit aqueous absorption by the iris and to physical and functional obstruction of the iridocorneal angles with inflammatory cells and debris
  • Iridal and ciliary body neoplasms and endophthalmitis can cause secondary glaucoma by infiltration of the outflow pathways

Diagnosis

Outline


DIAGNOSIS

Differential Diagnosis!!navigator!!

ERU, corneal ulceration, and endotheliitis may be associated with corneal edema, ocular pain, and vision loss in horses.

CBC/Biochemistry/Urinalysis!!navigator!!

N/A

Other Laboratory Tests!!navigator!!

Serologic tests for infectious diseases causing the anterior uveitis in horses with glaucoma may or may not identify the causative organism.

Imaging!!navigator!!

B-scan ultrasonography can demonstrate intraocular tumors associated with glaucoma in horses.

Other Diagnostic Procedures!!navigator!!

  • The diagnosis of equine glaucoma is made with the tonometric documentation of elevated IOP, and the presence of clinical signs specific to glaucoma, such as a mydriatic pupil and buphthalmia. ERU alone, in contrast, generally has a low IOP and a miotic pupil
  • The accurate measurement of IOP in the horse requires applanation or rebound tonometry. The mean IOP in the horse ranges from 17 to 28 mmHg. The IOP can vary at different times of day in horses with glaucoma and horses with ERU. It is important to measure IOP with the horse's head held above its heart to prevent falsely elevated readings

Pathologic Findings!!navigator!!

Preiridal fibrovascular membrane formation with secondary iridocorneal angle closure and trabecular meshwork sclerosis and collapse are noted. Since most cases of glaucoma in horses are secondary to uveitis, there is often infiltration of the uveal tissues with inflammatory cells and exudates.

Treatment

TREATMENT

Various combinations of drugs and surgery may be necessary to reduce the IOP to levels that are compatible with preservation of vision in horses with glaucoma. Glaucoma is particularly aggressive and difficult to control in the Appaloosa.

Medications

Outline


MEDICATIONS

Drug(s) of Choice!!navigator!!

  • Aqueous production may be reduced with the systemically administered carbonic anhydrase inhibitor acetazolamide (1–3 mg/kg QD PO), a β-adrenergic blocker such as 0.5% BID or TID timolol maleate, and a topical carbonic anhydrase inhibitor such as 2% dorzolamide BID or TID. Topical cholinergics and prostaglandin drugs may exacerbate iridocyclitis and should only be used with caution
  • Anti-inflammatory therapy, consisting of topically and systemically administered corticosteroids and/or topically and systemically administered NSAIDs (phenylbutazone 1 mg/kg BID PO; flunixin meglumine 250 mg BID PO) also appears to be beneficial in the control of IOP
  • When medical therapy is inadequate, Nd:YAG or diode laser cyclophotoablation may be a viable alternative for long-term IOP control. Nd:YAG laser cyclophotoablation is very effective at controlling IOP and maintaining vision in the horse. The author recommends 55 laser sites per eye for contact Nd:YAG laser cyclophotoablation in the horse, 5–6 mm posterior to the limbus, at a power setting of 12 W for 0.3 s duration per site. Diode lasers may be used in 55–70 sites at 1500 mW for 1500 ms per site. Laser cyclophotoablation may be performed in the standing horse. Endoscopic cyclophotoablation, wherein the ciliary processes are directly visualized and ablated with a diode laser, requires general anesthesia and an intraocular approach

Contraindications/Possible Interactions!!navigator!!

Conventional glaucoma treatment with miotics may provide varying amounts of IOP reduction in horses. A number of horses have increased IOP when administered topical miotics. As miotics can potentiate the clinical signs of uveitis, miotic therapy is generally considered to be contraindicated in glaucoma secondary to uveitis, and should be used cautiously, with careful IOP monitoring, in horses with mild or quiescent anterior uveitis.

Follow-up

Outline


FOLLOW-UP

Patient Monitoring!!navigator!!

  • Serial tonometry is required to document IOP spikes in horses with anterior uveitis and secondary glaucoma
  • Continued pupillary dilation is a sign of continued IOP elevation and optic nerve damage
  • Horses with glaucoma should be stall-rested until the condition is under control. Intraocular hemorrhage and increased severity of uveitis are sequelae to overexertion
  • Diet should be consistent with the activity and training level of the horse
  • Self-trauma should be avoided by use of hard- or soft-cup hoods

Prevention/Avoidance!!navigator!!

Breeding of horses with glaucoma is not recommended.

Possible Complications!!navigator!!

Chronic pain and blindness are complications.

Expected Course and Prognosis!!navigator!!

The horse eye seems to tolerate elevations in IOP for many months to years that would blind a dog; however, blindness is ultimately the end result. Buphthalmia can be associated with exposure keratitis.

Miscellaneous

Outline


MISCELLANEOUS

Associated Conditions!!navigator!!

  • ERU
  • Exposure keratitis and persistent corneal ulcerations

Age-Related Factors!!navigator!!

Older horses are at risk of developing glaucoma.

Zoonotic Potential!!navigator!!

N/A

Pregnancy/Fertility/Breeding!!navigator!!

N/A

Synonyms!!navigator!!

N/A

Abbreviations!!navigator!!

  • ERU = equine recurrent uveitis
  • IOP = intraocular pressure
  • Nd:YAG = neodymium:yttrium–aluminum–garnet
  • NSAID = nonsteroidal anti-inflammatory drug

Suggested Reading

Brooks DE. Ophthalmology for the Equine Practitioner, 2e. Jackson, WY: Teton NewMedia, 2008.

Brooks DE, Matthews AG. Equine ophthalmology. In: Gelatt KN, ed. Veterinary Ophthalmology, 4e. Ames, IA: Blackwell, 2007:11651274.

Gilger BC, ed. Equine Ophthalmology, 3e. Ames, IA: Wiley Blackwell, 2017.

Author(s)

Author: Caryn E. Plummer

Consulting Editor: Caryn E. Plummer

Acknowledgment: The author/editor acknowledges the prior contribution of Dennis E. Brooks.